Insulin glargine and lixisenatide and Peg Intron RP
Determining the interaction of Insulin glargine and lixisenatide and Peg Intron RP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: PegIntron, Pegintron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-PEG-3350 with Electolytes
- Insulin glargine and lixisenatide-PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride
- Insulin glargine and lixisenatide-PEG-Prep and Bisacodyl
- Insulin glargine and lixisenatide-PEG3350
- Insulin glargine and lixisenatide-Pegademase bovine
- Insulin glargine and lixisenatide-Pegademase Bovine Injection
- Peg Intron RP-Insulin glargine and lixisenatide Subcutaneous
- Peg Intron RP-Insulin glargine, recombinant Subcutaneous
- Peg Intron RP-Insulin glulisine
- Peg Intron RP-Insulin Glulisine (Cartridges and Pens)
- Peg Intron RP-Insulin Glulisine (Vials)
- Peg Intron RP-Insulin glulisine Subcutaneous